An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity.
Saved in:
| Title: | An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity. |
|---|---|
| Authors: | McClary WD; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Brandt DS; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Jennewein MF; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Singh J; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Beaver S; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Ykema MR; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Press C; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Melief E; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Bakken J; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Fusco P; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Lo E; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Battisti P; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Cross N; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Kasal DN; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Hartwig AT; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA., Casper C; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Bowen RA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA., Gerhardt A; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Voigt EA; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA. Electronic address: voigte@ohsu.edu. |
| Source: | Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Sep 10; Vol. 385, pp. 114054. Date of Electronic Publication: 2025 Jul 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40695376 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22McClary+WD%22">McClary WD</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Brandt+DS%22">Brandt DS</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Jennewein+MF%22">Jennewein MF</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Singh+J%22">Singh J</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Beaver+S%22">Beaver S</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Ykema+MR%22">Ykema MR</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Press+C%22">Press C</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Melief+E%22">Melief E</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Bakken+J%22">Bakken J</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Fusco+P%22">Fusco P</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Lo+E%22">Lo E</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Battisti+P%22">Battisti P</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Cross+N%22">Cross N</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Kasal+DN%22">Kasal DN</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Hartwig+AT%22">Hartwig AT</searchLink>; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.<br /><searchLink fieldCode="AU" term="%22Casper+C%22">Casper C</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Bowen+RA%22">Bowen RA</searchLink>; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.<br /><searchLink fieldCode="AU" term="%22Gerhardt+A%22">Gerhardt A</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA.<br /><searchLink fieldCode="AU" term="%22Voigt+EA%22">Voigt EA</searchLink>; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA. Electronic address: voigte@ohsu.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228607908%22">Journal of controlled release : official journal of the Controlled Release Society</searchLink> [J Control Release] 2025 Sep 10; Vol. 385, pp. 114054. <i>Date of Electronic Publication: </i>2025 Jul 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8607908 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201683659%22">01683659 </searchLink><i>NLM ISO Abbreviation: </i>J Control Release <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40695376 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jconrel.2025.114054 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 114054 Titles: – TitleFull: An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: McClary WD – PersonEntity: Name: NameFull: Brandt DS – PersonEntity: Name: NameFull: Jennewein MF – PersonEntity: Name: NameFull: Singh J – PersonEntity: Name: NameFull: Beaver S – PersonEntity: Name: NameFull: Ykema MR – PersonEntity: Name: NameFull: Press C – PersonEntity: Name: NameFull: Melief E – PersonEntity: Name: NameFull: Bakken J – PersonEntity: Name: NameFull: Fusco P – PersonEntity: Name: NameFull: Lo E – PersonEntity: Name: NameFull: Battisti P – PersonEntity: Name: NameFull: Cross N – PersonEntity: Name: NameFull: Kasal DN – PersonEntity: Name: NameFull: Hartwig AT – PersonEntity: Name: NameFull: Casper C – PersonEntity: Name: NameFull: Bowen RA – PersonEntity: Name: NameFull: Gerhardt A – PersonEntity: Name: NameFull: Voigt EA IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 09 Text: 2025 Sep 10 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1873-4995 Numbering: – Type: volume Value: 385 Titles: – TitleFull: Journal of controlled release : official journal of the Controlled Release Society Type: main |
| ResultId | 1 |